Serum periostin as a novel biomarker and therapeutic target in coronary heart disease.

Front Cardiovasc Med · 2025 · PMC12705617 · PMID 41409744

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Differential expression results indicated a highly significant difference in POSTN expression between CAD samples and control samples ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.